Publications
- The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients2018 | Faculty of Medicine in Hradec Králové
- Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia2022 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Intensive Care Infection Score (ICIS) is elevated in patients with moderate and severe COVID-19 in the early stages of disease2022 | Faculty of Medicine in Hradec Králové
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Blood cell analysers - significance of a dimorphic red blood cell population2021 | Faculty of Medicine in Hradec Králové
- Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome2021 | Faculty of Medicine in Hradec Králové
- Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Improved laboratory diagnostics of Streptococcus pneumoniae in respiratory tract samples through qPCR2020 | Faculty of Medicine in Hradec Králové
- Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma2020 | Faculty of Medicine in Hradec Králové
- First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...